Literature DB >> 27884799

The infectious hypoxia: occurrence and causes during Shigella infection.

Ellen T Arena1, Jean-Yves Tinevez2, Giulia Nigro1, Philippe J Sansonetti3, Benoit S Marteyn4.   

Abstract

Hypoxia is defined as a tissue oxygenation status below physiological needs. During Shigella infection, an infectious hypoxia is induced within foci of infection. In this review, we discuss how Shigella physiology and virulence are modulated and how the main recruited immune cells, the neutrophils, adapt to this environment.
Copyright © 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Infectious hypoxia; Neutrophils; Shigella

Mesh：

Year:  2016        PMID： 27884799     DOI： 10.1016/j.micinf.2016.10.011

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  13 in total

1.  Detection of Low Oxygen Microenvironments in a Murine Model of Invasive Pulmonary Aspergillosis Using Pimonidazole.

Authors:  Nora Grahl; Caitlin H Kowalski; Robert A Cramer
Journal:  Methods Mol Biol       Date:  2021

2.  Visualizing endocytic recycling and trafficking in live neurons by subdiffractional tracking of internalized molecules.

Authors:  Merja Joensuu; Ramon Martínez-Mármol; Pranesh Padmanabhan; Nick R Glass; Nela Durisic; Matthew Pelekanos; Mahdie Mollazade; Giuseppe Balistreri; Rumelo Amor; Justin J Cooper-White; Geoffrey J Goodhill; Frédéric A Meunier
Journal:  Nat Protoc       Date:  2017-11-30       Impact factor: 13.491

Review 3.  Enterobacteria and host resistance to infection.

Authors:  Eugene Kang; Alanna Crouse; Lucie Chevallier; Stéphanie M Pontier; Ashwag Alzahrani; Navoun Silué; François-Xavier Campbell-Valois; Xavier Montagutelli; Samantha Gruenheid; Danielle Malo
Journal:  Mamm Genome       Date:  2018-05-21       Impact factor: 2.957

Review 4.  Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.

Authors:  Benoît S Marteyn; Pierre-Régis Burgel; Laurent Meijer; Véronique Witko-Sarsat
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

Review 5.  Hypoxia, Hypoxia-Inducible Factor-1α, and Innate Antileishmanial Immune Responses.

Authors:  Valentin Schatz; Patrick Neubert; Franz Rieger; Jonathan Jantsch
Journal:  Front Immunol       Date:  2018-02-22       Impact factor: 7.561

6.  Preferential phosphatidylinositol 5-phosphate binding contributes to a destabilization of the VHS domain structure of Tom1.

Authors:  Wen Xiong; Tuo-Xian Tang; Evan Littleton; Arba Karcini; Iulia M Lazar; Daniel G S Capelluto
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

7.  HIF-1α is a key regulator in potentiating suppressor activity and limiting the microbicidal capacity of MDSC-like cells during visceral leishmaniasis.

Authors:  Akil Hammami; Belma Melda Abidin; Tania Charpentier; Aymeric Fabié; Annie-Pier Duguay; Krista M Heinonen; Simona Stäger
Journal:  PLoS Pathog       Date:  2017-09-11       Impact factor: 6.823

8.  Stress-induced host membrane remodeling protects from infection by non-motile bacterial pathogens.

Authors:  Caroline Tawk; Giulia Nigro; Ines Rodrigues Lopes; Carmen Aguilar; Clivia Lisowski; Miguel Mano; Philippe Sansonetti; Jörg Vogel; Ana Eulalio
Journal:  EMBO J       Date:  2018-11-02       Impact factor: 11.598

Review 9.  Neutrophil Metabolic Shift during their Lifecycle: Impact on their Survival and Activation.

Authors:  Louise Injarabian; Anne Devin; Stéphane Ransac; Benoit S Marteyn
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

10.  Shigella-mediated oxygen depletion is essential for intestinal mucosa colonization.

Authors:  Jean-Yves Tinevez; Ellen T Arena; Mark Anderson; Giulia Nigro; Louise Injarabian; Antonin André; Mariana Ferrari; François-Xavier Campbell-Valois; Anne Devin; Spencer L Shorte; Philippe J Sansonetti; Benoit S Marteyn
Journal:  Nat Microbiol       Date:  2019-08-05       Impact factor: 17.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.